Literature DB >> 9628820

The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21.

A Jackson1, P Panayiotidis, L Foroni.   

Abstract

Deletion of the long arm of chromosome 6 (6q) is one of the most common chromosomal abnormalities in human hematological malignancies. Two distinct regions of minimal deletion have been identified by loss of heterozygosity studies at 6q25 to 6q27 (RMD-1) and at 6q21 to 6q23 (RMD-2), suggesting the presence of one or more tumor suppressor genes. We have cloned sequences within RMD-2 and screened for novel genes using a combination of direct sequencing, cDNA library screening, and exon trapping. Sequences generated from a cosmid fragment, mapping within RMD-2, showed homology to the Drosophila tailless gene (tll). The human homologue of the Drosophila tailless gene (human tlx; MGMW-approved symbol, TLX) was subsequently cloned from a fetal brain cDNA library. The gene is a member of the steroid nuclear receptor superfamily and is homologous to tll genes from other species that are involved in brain development. TLX is predominately expressed in the brain and maps to RMD-2 at 6q21 between DNA markers FYN and D6S447, in a YAC clone that also contains marker D6S246. The contributions of this gene to human B-cell leukemia and to brain development are unknown at present. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628820     DOI: 10.1006/geno.1998.5270

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  21 in total

1.  Identification of a photoreceptor cell-specific nuclear receptor.

Authors:  M Kobayashi; S Takezawa; K Hara; R T Yu; Y Umesono; K Agata; M Taniwaki; K Yasuda; K Umesono
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Expression of the transcription factor, tailless, is required for formation of superficial cortical layers.

Authors:  P W Land; A P Monaghan
Journal:  Cereb Cortex       Date:  2003-09       Impact factor: 5.357

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Pathological aggression in "fierce" mice corrected by human nuclear receptor 2E1.

Authors:  Brett S Abrahams; Melvin C H Kwok; Eric Trinh; Saeed Budaghzadeh; Sazzad M Hossain; Elizabeth M Simpson
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 5.  Cell death in animal development.

Authors:  Piya Ghose; Shai Shaham
Journal:  Development       Date:  2020-07-24       Impact factor: 6.868

6.  Retina restored and brain abnormalities ameliorated by single-copy knock-in of human NR2E1 in null mice.

Authors:  J-F Schmouth; K G Banks; A Mathelier; C Y Gregory-Evans; M Castellarin; R A Holt; K Gregory-Evans; W W Wasserman; E M Simpson
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

7.  Tailless-like (TLX) protein promotes neuronal differentiation of dermal multipotent stem cells and benefits spinal cord injury in rats.

Authors:  Tao Wang; Xiaobao Ren; Jianqiong Xiong; Lei Zhang; Jifu Qu; Wenyue Xu
Journal:  Cell Mol Neurobiol       Date:  2011-01-22       Impact factor: 5.046

8.  Cell-type-specific regulation of the retinoic acid receptor mediated by the orphan nuclear receptor TLX.

Authors:  M Kobayashi; R T Yu; K Yasuda; K Umesono
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 9.  TLX: A master regulator for neural stem cell maintenance and neurogenesis.

Authors:  Mohammed M Islam; Chun-Li Zhang
Journal:  Biochim Biophys Acta       Date:  2014-06-13

10.  Chromosome 6 suffers frequent and multiple aberrations in thymoma.

Authors:  Masayoshi Inoue; Alexander Marx; Andreas Zettl; Philipp Ströbel; Hans-Konrad Müller-Hermelink; Petr Starostik
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.